These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

751 related articles for article (PubMed ID: 36677316)

  • 1. Vancomycin Resistance in
    Li G; Walker MJ; De Oliveira DMP
    Microorganisms; 2022 Dec; 11(1):. PubMed ID: 36677316
    [No Abstract]   [Full Text] [Related]  

  • 2. Detection of Vancomycin Resistance among Enterococcus faecalis and Staphylococcus aureus.
    Rengaraj R; Mariappan S; Sekar U; Kamalanadhan A
    J Clin Diagn Res; 2016 Feb; 10(2):DC04-6. PubMed ID: 27042459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time-kill kinetics of oritavancin and comparator agents against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium.
    McKay GA; Beaulieu S; Arhin FF; Belley A; Sarmiento I; Parr T; Moeck G
    J Antimicrob Chemother; 2009 Jun; 63(6):1191-9. PubMed ID: 19369269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agricultural Origins of a Highly Persistent Lineage of Vancomycin-Resistant
    Rushton-Green R; Darnell RL; Taiaroa G; Carter GP; Cook GM; Morgan XC
    Appl Environ Microbiol; 2019 Jul; 85(13):. PubMed ID: 31028029
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antibiotic susceptibility analysis of Enterococcus spp. isolated from urine].
    Rudy M; Nowakowska M; Wiechuła B; Zientara M; Radosz-Komoniewska H
    Przegl Lek; 2004; 61(5):473-6. PubMed ID: 15515808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycopeptide resistance in Enterococcus spp. and coagulase-negative staphylococci from hospitalised patients in Germany: occurrence, characteristics and dalbavancin susceptibility.
    Kresken M; Klare I; Wichelhaus TA; Wohlfarth E; Layer-Nicolaou F; Neumann B; Werner G;
    J Glob Antimicrob Resist; 2022 Mar; 28():102-107. PubMed ID: 34958996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nigella sativa oil extract: A natural novel specific conjugal transfer inhibitor of vancomycin resistance from vanA/B-resistant Enterococcus faecium to Staphylococcus aureus.
    Ahmad AAM; Gharib AA; Elshorbgy I; Elewasy OA; Elmowalid GA
    J Appl Microbiol; 2022 Aug; 133(2):619-629. PubMed ID: 35395119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of growth phase and pH on the in vitro activity of a new glycopeptide, oritavancin (LY333328), against Staphylococcus aureus and Enterococcus faecium.
    Mercier RC; Stumpo C; Rybak MJ
    J Antimicrob Chemother; 2002 Jul; 50(1):19-24. PubMed ID: 12096002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired vancomycin resistance in clinically relevant pathogens.
    Werner G; Strommenger B; Witte W
    Future Microbiol; 2008 Oct; 3(5):547-62. PubMed ID: 18811239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repurposing of the Tamoxifen Metabolites to Treat Methicillin-Resistant Staphylococcus epidermidis and Vancomycin-Resistant Enterococcus faecalis Infections.
    Miró-Canturri A; Vila-Domínguez A; Caretero-Ledesma M; Ayerbe-Algaba R; Pachón J; Jiménez-Mejías ME; Smani Y
    Microbiol Spectr; 2021 Oct; 9(2):e0040321. PubMed ID: 34668743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opposite effect of vancomycin and D-Cycloserine combination in both vancomycin resistant Staphylococcus aureus and enterococci.
    Boudrioua A; Li Y; Hartke A; Giraud C
    FEMS Microbiol Lett; 2020 Apr; 367(8):. PubMed ID: 32277698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Species, antibiotic susceptibility profiles and van gene frequencies among enterococci isolated from patients at Mulago National Referral Hospital in Kampala, Uganda.
    Kateete DP; Edolu M; Kigozi E; Kisukye J; Baluku H; Mwiine FN; Najjuka CF
    BMC Infect Dis; 2019 May; 19(1):486. PubMed ID: 31151413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent Challenges for Clinicians: Emergence of Methicillin-Resistant Staphylococcus aureus, Vancomycin Resistance, and Current Treatment Options.
    Tarai B; Das P; Kumar D
    J Lab Physicians; 2013 Jul; 5(2):71-8. PubMed ID: 24701097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of available and investigational antibiotics for complicated skin infections and treatment-resistant Staphylococcus aureus and enterococcus.
    Scheinfeld N
    J Drugs Dermatol; 2007 Jan; 6(1):97-103. PubMed ID: 17373167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proficiency of Italian clinical laboratories in detecting reduced glycopeptide susceptibility in Enterococcus and Staphylococcus spp. using routine laboratory methodologies.
    Jones ME; Gesu G; Ortisi G; Sahm DF; Critchley IA; Goglio A;
    Clin Microbiol Infect; 2002 Feb; 8(2):101-11. PubMed ID: 11952723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm.
    Weigel LM; Donlan RM; Shin DH; Jensen B; Clark NC; McDougal LK; Zhu W; Musser KA; Thompson J; Kohlerschmidt D; Dumas N; Limberger RJ; Patel JB
    Antimicrob Agents Chemother; 2007 Jan; 51(1):231-8. PubMed ID: 17074796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vancomycin resistance VanS/VanR two-component systems.
    Hong HJ; Hutchings MI; Buttner MJ;
    Adv Exp Med Biol; 2008; 631():200-13. PubMed ID: 18792691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Vancomycin on Cytoplasmic Peptidoglycan Intermediates and
    Gargvanshi S; Vemula H; Gutheil WG
    J Bacteriol; 2021 Jul; 203(16):e0023021. PubMed ID: 34060906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Semisynthetic glycopeptide antibiotics derived from LY264826 active against vancomycin-resistant enterococci.
    Nicas TI; Mullen DL; Flokowitsch JE; Preston DA; Snyder NJ; Zweifel MJ; Wilkie SC; Rodriguez MJ; Thompson RC; Cooper RD
    Antimicrob Agents Chemother; 1996 Sep; 40(9):2194-9. PubMed ID: 8878606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiogram of Urinary
    Bhat NR; Shivashankar SBK; Dhanashree B
    Infect Disord Drug Targets; 2021; 21(1):146-150. PubMed ID: 32242789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.